FDA Approved: PERTZYE — Original Application (Digestive Care, Inc.)

View source ↗

Summary

PERTZYE (pancrelipase) was approved on an original application for the treatment of exocrine pancreatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatitis
• Postoperative Pancreatic Insufficiency

Drugs mentioned

• PERTZYE (PANCRELIPASE)

Snippet

ORIG AP for PERTZYE (PANCRELIPASE)